Minerva Neurosciences, Inc. (NERV) Total liabilities 2017–2024
Minerva Neurosciences, Inc. (NERV) total liabilities at each fiscal year-end, per SEC filings.
$62.8MFY2024 · since FY2017: $52.1M → $62.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $62.8M | -26.4% |
| FY2023 | $85.4M | +13.6% |
| FY2022 | $75.1M | +8.6% |
| FY2021 | $69.1M | +1293.1% |
| FY2020 | $5.0M | -90.0% |
| FY2019 | $49.7M | +1.7% |
| FY2018 | $48.9M | -6.2% |
| FY2017 | $52.1M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice